Explore our latest published papers, where we share in-depth insights into various aspects of cannabis research:

1. Topical cannabidiol is well tolerated in individuals with a history of elite physical performance and chronic lower extremity pain – Cannabidiol (CBD) is a potential therapeutic for pain management. Yet, there exists a dearth of studies of its tolerability and efficacy, especially in special populations. Former elite athletes are a special population both susceptible to chronic pain and also highly trained and attuned to assess medication tolerability concerns. The purpose of the present open-label pilot study was to assess the tolerability of CBD in this population.
   • https://rdcu.be/dik5Q

At Tiger Research Group, we are dedicated to advancing cannabis research and promoting evidence-based knowledge. Our published papers contribute to the growing body of research that supports the potential benefits of cannabis for medical and therapeutic purposes.

Join us on our journey of empowerment, compassion, and scientific excellence. Together, let’s transform perceptions and make a positive impact on the world through cannabis education and research.